CN101185730B - Ache relieving mixture for treating urarthritis - Google Patents
Ache relieving mixture for treating urarthritis Download PDFInfo
- Publication number
- CN101185730B CN101185730B CN2007101004298A CN200710100429A CN101185730B CN 101185730 B CN101185730 B CN 101185730B CN 2007101004298 A CN2007101004298 A CN 2007101004298A CN 200710100429 A CN200710100429 A CN 200710100429A CN 101185730 B CN101185730 B CN 101185730B
- Authority
- CN
- China
- Prior art keywords
- percent
- radix
- gouty arthritis
- rhizoma
- pheretima
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a pain-relieving mixture for the treatment of gouty arthritis, which pertains to the field of pharmaceutical formulations, the technology is characterized in that: the parts by weight of the raw materials are: 6 to 10 percent amur corktree bark, 12 to 16 percent sevenlobed yam rhizome, 4 to 6 percent rhubarb, 8 to 12 percent Japanese honeysuckle stem, 6 to 9 percent Indian iphigenia bulb, 12 to 16 percent spreading hedyotis herb, 6 to 10 percent glabrous greenbrier rhizome, 4 to 6 percent frankincense, 4 to 6 percent myrrh, 6 to 10 percent clematis root, 6 to 10 percent largeleaf gentian root and 6 to 9 percent earthworm, and the sum of the percentages of the components of the raw materials is equal to 100 percent. The invention can effectively alleviate the symptoms of gouty arthritis, prevent and treat the repeated attacks of gouty arthritis, lower blood uric acid, have no toxicity or side effects and have definite efficacy.
Description
Technical field
The present invention relates to the pharmaceutical formulation field, specifically a kind of flat ache relieving mixture that is used for the treatment of gouty arthritis.
Background technology
Gouty arthritis is because purine metabolic disturbance causes the too much or drainage minimizing of uricopoiesis, cause uric acid increase in serum and the body fluid, urate crystal, be deposited on the inflammatory reaction that joint part causes, blood uric acid increases makes that it shows effect repeatedly, the pathologic basis of protracted course of disease.Modern medicine adopts colchicine and/or nonsteroidal anti inflammatory medicine and/or glucocorticoid medicine to treat the outbreak of its acute symptom, catabasis is adopted medicine (allopurinol) that suppresses uricopoiesis and medicine (probenecid, sulphinpyrazone, the benzbromarone) uric acid reducing that promotes urate excretion, the outbreak of prevention gouty arthritis.But can cause that owing to said medicine many untoward reaction such as erythra, gastrointestinal reaction, hepatic and renal function damage, bone marrow depression even respiration inhibition have influenced their application.Therefore Chinese medicine has its uniqueness and superiority in the treatment of hyperuricemia and gouty arthritis, is bringing into play important effect.Yet up to the present, the treatment hyperuricemia produced in batches of more satisfactory and typing, the Chinese patent medicine preparation of the acute and chronic gouty arthritis of control are not seen both at home and abroad as yet.
Summary of the invention
In order to overcome the deficiency of above-mentioned technology, the invention provides a kind of symptom that both can effectively improve gouty arthritis, prevent and treat the outbreak repeatedly of gouty arthritis, can reduce blood uric acid again, no obvious toxic-side effects, determined curative effect, the flat ache relieving mixture of Chinese traditional compound medicine with low cost.
The technical solution adopted for the present invention to solve the technical problems is: adopting Cortex Phellodendri, Rhizoma Dioscoreae Septemlobae, Radix Et Rhizoma Rhei, Caulis Lonicerae, Pseudobulbus cremastrae seu pleiones, Herba Hedyotidis Diffusae, Rhizoma Smilacis Glabrae, Olibanum, Myrrha, Radix Clematidis, Radix Gentianae Macrophyllae, Pheretima is that feedstock production forms.Clean said medicine is selected, mix by a certain percentage, decoct then, remove slag filtrate, sterilization makes mixture after refining; Its technical characterictic is: with the weight portion of cleaning is that Cortex Phellodendri 6-10%, castor are separated 12-16%, Radix Et Rhizoma Rhei 4-6%, Caulis Lonicerae 8-12%, Pseudobulbus cremastrae seu pleiones 6-9%, Herba Hedyotidis Diffusae 12-16%, Rhizoma Smilacis Glabrae 6-10%, Olibanum 4-6%, Myrrha 4-6%, Radix Clematidis 6-10%, Radix Gentianae Macrophyllae 6-10%, Pheretima 6-9% uniform mixing (each raw material components percentage ratio sum equals absolutely), soaked 3-10 hour, decoct then more than 60 minutes, through routine remove slag filtration, high pressure, sterilization, after refining, make filtrate.
The invention has the beneficial effects as follows that processing technique is simple, the drug mixture cost of material of being produced is low, take the no obvious toxic-side effects in back, determined curative effect, not only symptom and sign are obviously improved, joint motion is flexible, and blood uric acid reduces to normally, and total effective rate is 93%.
The specific embodiment
Embodiment 1:
It is that feedstock production forms that the present invention adopts Cortex Phellodendri, Rhizoma Dioscoreae Septemlobae, Radix Et Rhizoma Rhei, Caulis Lonicerae, Pseudobulbus cremastrae seu pleiones, Herba Hedyotidis Diffusae, Rhizoma Smilacis Glabrae, Olibanum, Myrrha, Radix Clematidis, Radix Gentianae Macrophyllae, Pheretima.Its components based on weight percentage Cortex Phellodendri 8, castor separate 14, Radix Et Rhizoma Rhei 5, Caulis Lonicerae 10, Pseudobulbus cremastrae seu pleiones 8, Herba Hedyotidis Diffusae 14, Rhizoma Smilacis Glabrae 8, Olibanum 5, Myrrha 5, Radix Clematidis 8, Radix Gentianae Macrophyllae 8, Pheretima 7, get above-mentioned raw materials total amount double centner, selected clean uniform mixing, steeped 3-10 hour with the 20000mI water logging at ambient temperature, decoct then more than 60 minutes, remove slag through routine after the technologies such as filtration, high pressure, sterilization, gained filtrate is stand-by.
Therapeutic Principle of the present invention: the gout acute stage, mostly be damp-heat accumulation, impregnated in the muscle joint, the heresy of the diseases caused by exogenous pathogenic factor rheumatism of holding concurrently again, and the invasion and attack meridians, QI-blood circulation is not smooth, stagnation of QI and blood may bring about pain.Pathological factor is the turbid malicious expectorant stasis of blood, controls with promoting blood circulation and stopping pain, clearing away heat-damp and promoting diuresis, reduces phlegm that it is turbid to dispel, and makes vital QI recovered after pathogens eliminated.The clear damp-heat in lower-JIAO of Cortex Phellodendri is separated damp and hot sore in the component of the present invention, the clean source of clear stream; Radix Et Rhizoma Rhei leads to intestinal detoxifcation, eliminating blood stasis and inducing menstruation, logical stool, diuresis, makes heresy that outlet be arranged; Rhizoma Dioscoreae Septemlobae divides sharp pure and impure, Rhizoma Smilacis Glabrae detoxification and promoting urination, relaxes through collateral dredging, but two medicines all removing dampness and detoxicating, the merit of easing joint movement is arranged, and with Radix Et Rhizoma Rhei compatibility using pungent drugs for dispersion and bitter drugs for purgation before and after two the moon, turbid poison is gone out with defecation; Pseudobulbus cremastrae seu pleiones, Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, and contain the colchicine composition in the Pseudobulbus cremastrae seu pleiones bulb, the treatment acute gouty arthritis has specially good effect; Olibanum, Myrrha removing blood stasis promoting the circulation of QI to relieve pain have rapid, powerful analgesic activity; Caulis Lonicerae has the merit of heat-clearing and toxic substances removing, dredge the meridian passage, can eliminate the wind heat of meridians and numbness is treated in pain relieving; Radix Clematidis is apt to away and is not kept, and can declare logical twelve channels and collaterals, makes the stasis in patient's meridians open-minded, and the stagnation of QI and blood may bring about pain symptom is improved; Radix Gentianae Macrophyllae expelling wind and removing dampness collateral dredging closes the power that Radix Clematidis is strengthened diffusing impediment and relieving pain; The salty-cold heat clearing away of Pheretima, and can attack and scurry the meridians reducing swelling and alleviating pain.All medicines generally have the effect of analgesic, analgesia, antiinflammatory, antibacterial, uric acid resisting in the modern pharmacological research demonstration side, can remove joint effectively and swell and ache, thereby alleviate the acute gouty arthritis symptom.
But each raw material of the present invention also blended embodiment of the listed ratio of according to the form below (weight portion) is realized.Its processing technique is identical with embodiment 1.
| Embodiment | Cortex Phellodendri | Rhizoma Dioscoreae Septemlobae | Radix Et Rhizoma Rhei | Caulis Lonicerae | Pseudobulbus cremastrae seu pleiones | Herba Hedyotidis Diffusae | Rhizoma Smilacis Glabrae | Olibanum | Myrrha | Radix Clematidis | Radix Gentianae Macrophyllae | Pheretima |
| 2 | 6 | 16 | 4 | 12 | 6 | 16 | 6 | 4 | 5 | 10 | 6 | 9 |
| 3 | 7 | 15 | 5 | 11 | 7 | 15 | 7 | 5 | 5 | 9 | 8 | 6 |
| 4 | 9 | 13 | 6 | 9 | 8 | 13 | 9 | 6 | 6 | 7 | 7 | 7 |
| 5 | 10 | 12 | 6 | 8 | 9 | 12 | 10 | 5 | 4 | 6 | 10 | 8 |
Below in conjunction with my institute, promptly the clinical preliminary test that carries out of Shandong Province Wendeng Central Hospital, Weihai City is done to describe in further detail to the present invention:
1, case is selected: this organizes 60 examples, male 50 examples, women 10 examples, age 25-60 year, 34.6 years old mean age; The course of disease is 2-18, average 5.8 years.
2, diagnostic criteria: formulate: more than the acute arthritis outbreak once, and in a day, reach a climax according to American Rheumatism Association's diagnostic criteria in 1977; Acute inflammation is confined to indivedual joints; Whole joint is kermesinus; First metatarsophalangeal joints swells and ache; One-sided tarsal joint acute inflammation; Tophus suspicious or that confirm is arranged; Hyperuricemia; The asymmetry arthroncus; Outbreak can stop voluntarily.All possess above-mentioned 6 above persons and can make a definite diagnosis.
3, exclusion standard: do not conform to above-mentioned diagnostic criteria person; Age at under-18s or more than 70 years old, gestation or women breast-feeding their children, allergic constitution and to this medicine allergy sufferers; Be associated with cardiovascular, cerebrovascular, liver, kidney and disease of hematopoietic system, insane; Late period arthritis severe deformity, stiff disability person; Can not stop using influences this medication effect medicine person.
4, criterion of therapeutical effect: produce effects: symptom and sign disappear, and joint motion is normal, and blood uric acid is reduced to normally.Effectively: symptom and sign are obviously improved, and joint motion is more preceding flexibly, and blood uric acid descends.Invalid: symptom and sign does not have improvement, the lab testing no change before and after the treatment.
5, Therapeutic Method: take flat ache relieving mixture 50ml at every turn, divide every day and take for early, middle and late three times, 2 weeks were a course of treatment.
6, therapeutic outcome: produce effects 14 examples, effective 42 examples, invalid 6 examples, obvious effective rate 23%, effective percentage 70%, inefficiency 7%, total effective rate is 93%.
Claims (1)
1. flat ache relieving mixture for the treatment of gouty arthritis, adopt Cortex Phellodendri Rhizoma Dioscoreae Septemlobae, Radix Et Rhizoma Rhei, Caulis Lonicerae, Pseudobulbus cremastrae seu pleiones, Herba Hedyotidis Diffusae, Rhizoma Smilacis Glabrae, Olibanum, Myrrha, Radix Clematidis, Radix Gentianae Macrophyllae, Pheretima is that feedstock production forms, said medicine is selected clean, mix, decoct then, remove slag filtrate, sterilization, after refining, make mixture, its technical characterictic is: with the percentage by weight of cleaning is Cortex Phellodendri 6～10% Rhizoma Dioscoreae Septemlobae 12～16%, Radix Et Rhizoma Rhei 4～6%, Caulis Lonicerae 8～12%, Pseudobulbus cremastrae seu pleiones 6～9%, Herba Hedyotidis Diffusae 12～16%, Rhizoma Smilacis Glabrae 6～10%, Olibanum 4～6%, Myrrha 4～6%, Radix Clematidis 6～10%, Radix Gentianae Macrophyllae 6～10%, Pheretima 6～9% uniform mixing, each raw material components percentage ratio sum equals absolutely, soaked 3～10 hours, decoct 60 minutes then, through the routine filtration of removing slag, autoclaving makes after refining.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101004298A CN101185730B (en) | 2006-11-21 | 2007-04-04 | Ache relieving mixture for treating urarthritis |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610070413 | 2006-11-21 | ||
| CN200610070413.2 | 2006-11-21 | ||
| CN2007101004298A CN101185730B (en) | 2006-11-21 | 2007-04-04 | Ache relieving mixture for treating urarthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101185730A CN101185730A (en) | 2008-05-28 |
| CN101185730B true CN101185730B (en) | 2010-09-08 |
Family
ID=39478487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101004298A Expired - Fee Related CN101185730B (en) | 2006-11-21 | 2007-04-04 | Ache relieving mixture for treating urarthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101185730B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670058B (en) * | 2009-09-25 | 2011-06-22 | 孙红梅 | Traditional Chinese medicine composition for treating gout |
| CN101850063A (en) * | 2010-04-02 | 2010-10-06 | 贵阳春科药业技术研发有限公司 | Medicinal preparation for preventing and treating gout and preparation method |
| CN101897767B (en) * | 2010-07-26 | 2011-11-30 | 浙江中医药大学 | Urarthritis lavipeditum powder |
| CN102309705B (en) * | 2011-07-21 | 2013-08-28 | 杭州市中医院 | Medicine for reducing serum uric acid, preparation method thereof and purpose thereof |
| CN102657737B (en) * | 2012-03-21 | 2013-10-02 | 潘�清 | Medicament for treating acute gouty arthritis |
| CN104116823B (en) * | 2013-04-26 | 2018-04-17 | 谢兴文 | A kind of caulis lonicerae particle |
| CN103301288B (en) * | 2013-06-12 | 2014-08-27 | 邬存娟 | Traditional Chinese medicine composition for treating gouty arthritis |
| CN104306694B (en) * | 2013-12-01 | 2017-09-15 | 福建省立医院 | A kind of Chinese medicine composition preparation method and medical usage for treating gout |
| CN103690846A (en) * | 2013-12-10 | 2014-04-02 | 赵财 | External traditional Chinese medicinal fuming and washing lotion prescription for treating gout |
| CN110478452B (en) * | 2019-10-16 | 2020-02-04 | 江西中医药大学附属医院 | Traditional Chinese medicine composition for treating gout and preparation method thereof |
| CN113384656A (en) * | 2021-06-17 | 2021-09-14 | 云南省中医医院(云南中医药大学第一附属医院) | Traditional Chinese medicine external fossil cream for treating subcutaneous tophus and preparation method thereof |
| CN113769030A (en) * | 2021-10-24 | 2021-12-10 | 恩施硒谷科技股份有限公司 | Chinese herbal medicine capable of preventing gout and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375298A (en) * | 2001-01-04 | 2002-10-23 | 黄兆元 | Pain-relieving notoginseng mixture |
-
2007
- 2007-04-04 CN CN2007101004298A patent/CN101185730B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375298A (en) * | 2001-01-04 | 2002-10-23 | 黄兆元 | Pain-relieving notoginseng mixture |
Non-Patent Citations (5)
| Title |
|---|
| 方策等.痛风性关节炎的中西药治疗研究.中医正骨11 10.1999,11(10),51-52. * |
| 苏文瑞.痛风性关节炎的中医药治疗研究进展.吉林中医药23 11.2003,23(11),53-54. * |
| 解国华等.中医药治疗痛风性关节炎的研究.北京中医杂志21 2.2002,21(2),122-126. * |
| 谢纬等.中医药治疗痛风的进展.河南中医学院学报18 106.2003,18(106),86-88. * |
| 郭峰等.痛风性关节炎的中医药治疗研究辑要.中医药学刊22 2.2004,22(2),275-276. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101185730A (en) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101185730B (en) | Ache relieving mixture for treating urarthritis | |
| CN100360160C (en) | Medicine for treating dermatosis and its prepn | |
| CN102302661A (en) | Chinese medicinal composition for treating skin diseases | |
| CN102319397A (en) | Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method | |
| CN102727758A (en) | Traditional Chinese medicine enema for treating ulcerative colitis | |
| CN1555857A (en) | Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation | |
| CN116747280A (en) | Traditional Chinese medicine fermentation preparation for preventing and treating gout and preparation method and application thereof | |
| CN106138569A (en) | A kind of Chinese medicine composition treating chronic wound and application thereof | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN102579679B (en) | Chinese medicinal external lotion and nursing method for treating diaper dermatitis of infants | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN104840553B (en) | A kind of Chinese medicine for treating chronic renal failure | |
| CN109010644A (en) | A kind of gynaecology's draft antibacterial liquid | |
| CN1194740C (en) | Chinese medicine powder for treating cerebrovascular diseases | |
| CN104523942B (en) | One treats colpitic external preparation | |
| CN115252743B (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating or preventing arthralgia | |
| CN102423419B (en) | External traditional Chinese preparation for treating bedsore | |
| CN101618118B (en) | Application of Chinese medicinal composition in preparing medicament for treating cystitis | |
| CN103083445A (en) | Traditional Chinese medicine preparation used for treating skin ulcers, and preparation method thereof | |
| CN101057921B (en) | Traditional Chinese medicine capsule for treating prostatic hyperplasia | |
| CN105688096A (en) | Traditional Chinese medicine composition for treating gout | |
| CN1298342C (en) | Medicine for treating thromboangiitis and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100908 Termination date: 20110404 |